PVI
VRTX icon

Pine Valley Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Pine Valley Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$686K Buy
1,381
+26
+2% +$11.5K 0.03% 353
2026
Q1 		$605K Buy
1,355
+5
+0.4% +$2.33K 0.03% 351
2025
Q4 		$612K Hold
1,350
– – 0.03% 338
2025
Q3 		$529K Buy
1,350
+9
+0.7% +$3.76K 0.03% 346
2025
Q2 		$597K Hold
1,341
– – 0.03% 321
2025
Q1 		$650K Sell
1,341
-86
-6% -$40.1K 0.04% 305
2024
Q4 		$575K Hold
1,427
– – 0.03% 316
2024
Q3 		$664K Buy
1,427
+10
+0.7% +$4.8K 0.04% 284
2024
Q2 		$664K Buy
1,417
+2
+0.1% +$868 0.04% 270
2024
Q1 		$591K Sell
1,415
-221
-14% -$93.4K 0.04% 286
2023
Q4 		$666K Sell
1,636
-269
-14% -$99.4K 0.05% 264
2023
Q3 		$662K Buy
1,905
+393
+26% +$137K 0.06% 253
2023
Q2 		$532K Buy
+1,512
New +$509K 0.05% 255

Other funds holding VRTX

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Pine Valley Investments's VRTX Position: Q2 2026 in Review

Pine Valley Investments increased its Vertex Pharmaceuticals (VRTX) stake by 1.9% in Q2 2026, buying an estimated $11.5K and bringing the position to 1,381 shares worth $686K. The position accounts for 0.03% of the portfolio, ranked #353.

Pine Valley Investments first reported a position in VRTX in Q2 2023 and has held it in 13 quarters since. 892 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Pine Valley Investments held 1,381 shares of Vertex Pharmaceuticals worth $686K as of Q2 2026.
  • Pine Valley Investments bought 26 Vertex Pharmaceuticals shares in Q2 2026, an estimated $11.5K.
  • Vertex Pharmaceuticals made up 0.03% of Pine Valley Investments's portfolio in Q2 2026, its #353 holding.
  • Pine Valley Investments first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 892 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.